| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate |
2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d7233e96b6366153f6fe4c019dfde35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c10bc55bf59e55a531703a9607c6a37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2afd29acafe9c0d3e5277d8e3e9bea5 |
| publicationDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004058943-A1 |
| titleOfInvention |
Medicinal composition for treatment of chronic cardiac failure |
| abstract |
A pharmaceutical composition for ameliorating exercise tolerance depression of cases of chronic heart failure, which contains, as the active ingredient, N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrim idinyl]-2-phenylethenesulfonamide or its pharmaceutically-acceptable salt thereof as the active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115232784-A |
| priorityDate |
2001-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |